Frontiers in Pharmacology
October 3, 2022
Célia Cabral, Claudia Carbone, Pamela Maher et al.
Psychoactive natural products: Potential in the treatment of brain diseases and strategies to improve delivery For this special issue, focusing on psychoactive natural products with therapeutic potential for the treatment of brain diseases, we have invited authors to contribute with research and review articles illustrating and stimulating the continuing effort in drug discovery and drug...
Journal of Psychedelic Studies
September 21, 2022
Thais Guimarães Bourscheid, Leonardo Corrêa Cardoso, Marcelo Henrique Nascimento Santana et al.
3 citations
Abstract Snuff is a fine aromatic powder composed of dried and thin leaves combined with tobacco, roots, peels, and seeds. Its use for indigenous religious purposes has appeared since pre-Columbian period in various localities of American continent. Practice is considered sacred in indigenous culture and suffered from trivialization of consumption due to influence of colonizers, which triggered...
Anesthesiology
September 12, 2022
Albert Dahan, Erik Olofsen, Thomas K. Henthorn et al.
3 citations
We thank Bowdle et al.1 for their interest in our article,2 and for the important issue they raise, paraphrased as follows: what is the best anthropocentric description of the "mind-altering" effects of a heterogeneous group of compounds and drugs that act at the brain and cause significant changes in mental state. The group of drugs that we are referring to includes N-methyl-d-aspartate (NMDA)...
Psychiatric Annals
September 1, 2022
Mitch Earleywine, Zachary Herrmann
5 citations
Initial promise and dire need have inspired the multiple research programs of the second psychedelic renaissance. Serotonergic psychedelics (psilocybin, lysergic acid diethylamide, and ayahuasca) have decreased end-of-life anxiety in cancer patients, treatment-resistant depression, alcohol dependence, social anxiety in autistic adults, and nicotine dependence when applied with supportive...
Central European journal of public health
September 1, 2022
Pavla Chomynová, Rita Kočárová, Filip Kňažek et al.
2 citations
Different psychoactive substances are widely used in today's society. So far limited data are available on the use of psychedelics in the general population. The main aim of this study is to estimate the numbers of users of substances with psychedelic properties (classical psychedelics, cannabis, ecstasy, and ketamine) in the Czech Republic. Data from two samples enrolled in representative...
Addiction Biology
August 31, 2022
Elena Giné, Javier Calleja‐conde, José Á. Morales-García et al.
49 citations
Abstract Classic psychedelics refer to substances such as lysergic acid diethylamide (LSD), psilocybin, ayahuasca, and mescaline, which induce altered states of consciousness by acting mainly on 5‐HT 2A receptors. Recently, the interest of psychedelics as pharmacological treatment for psychiatric disorders has increased significantly, including their use on problematic use of alcohol. This...
Anthropologica
August 29, 2022
Nehemias Pino, Michael A. Uzendoski
1 citation
El presente artículo analiza los imaginarios contemporáneos sobre el caucho en el medio Napo de fines del siglo XIX e inicios del XX en la Comunidad Nativa de Angoteros. En éste generamos una discusión teórica que nos aproxime a comprender una enmarañada memoria que, sugerimos, se halla en una textualidad fenomenológica en un mundo perspectivista como el Amazónico. En nuestro material...
Self - Revista do Instituto Junguiano de São Paulo
August 26, 2022
Daniel Françoli Yago, Katia Caroline Modena Couto, Pedro Alegria Carrilho Marambio
Trata-se de estudo de caso que sintetiza as principais conclusões de uma pesquisa empírica e qualitativa que teve como objetivo geral analisar as formas da experiência numinosa na vivência do ritual com ayahuasca. Os objetivos específicos foram observar e analisar quais são os símbolos que emergem do ritual e observar aspectos psicológicos a partir de entrevistas. Em relação à metodologia,...
Journal of Psychopharmacology
August 26, 2022
Joost J. Breeksema, Bouwe Kuin, Jeanine Kamphuis et al.
171 citations
Introduction: Small-scale clinical studies with psychedelic drugs have shown promising results for the treatment of several mental disorders. Before psychedelics become registered medicines, it is important to know the full range of adverse events (AEs) for making balanced treatment decisions. Objective: To systematically review the presence of AEs during and after administration of...
PLoS One
August 24, 2022
Mary M. Sweeney, Sandeep M. Nayak, Ethan Hurwitz et al.
60 citations
Both psychedelic drug experiences and near-death experiences can occasion changes in perspectives on death and dying, but there have been few direct comparisons of these phenomena. This study directly compared psychedelic occasioned and non-drug experiences which altered individuals’ beliefs about death. Individuals who reported an experience that altered their beliefs about death occasioned by...